Report cover image

Insulin Delivery Devices Market

Publisher Fortune Business Insights Pvt. Ltd.
Published Sep 01, 2024
Length 160 Pages
SKU # FOB19185739

Description

Insulin Delivery Devices Market



Growth Factors of Insulin Delivery Devices Market

The insulin delivery devices market size was valued at USD 8.93 billion in 2023, and the market is now projected to grow from USD 10.11 billion in 2024 to USD 31.98 billion by 2032, exhibiting a CAGR of 15.5% during the forecast period of 2024-2032.

The overall global market for insulin delivering devices has been slow to grow during the COVID-19 outbreak since the devices had not reached many patients and the patients have not visited clinics for their insulin treatment. This affected the need for diabetes care devices and revenues for the key firms, in terms of growth rate. Also, the disruptions in the supplies anticipated and slowed down the market growth during this period.

With the global incidence of the diabetes mellitus rising, management devices are enjoying growing popularity with patients. Government and market players are working on creating awareness about the disease and the available treatments in the market which will push the sales of insulin delivery devices. Such measures can be seen as efforts towards enhancing patients’ access and Self-Management of the disease.

The global rise of diabetes is putting pressure on stakeholders on developing better technologies to meet consumer needs. Current trends in technology are seen to birth diverse delivery systems such as non-insulin delivery systems. Of main interest are the development of technologies that might facilitate care control and patient comfort in diabetes.

Comprehensive Analysis of Insulin Delivery Devices Market

The insulin delivery devices market growth is rising at an exponential rate due to its market segmentation. This market expansion correctly offers a detailed nearby assessment considering the dominant supply and demand forces that impact the industry. These segmentations are methodically segregated by product analysis, by disease indication analysis, and by distribution channel analysis. By product analysis include insulin pumps, insulin pens, insulin syringes, and others. By disease indication analysis include type 1 and type 2. By distribution channel analysis include hospital pharmacies, retail pharmacies, and online pharmacies.

The North America region lead the insulin delivery devices market share by benefitting a market size of USD 4.71 billion in 2023 due to rising prevalence of diabetes in the U.S., Canada, and other countries.

The top players have a significant responsibility in the healthcare industry for confirming industrial prospectus growth and determining the market trends. These players include, Medtronic, Tandem Diabetes Care, Inc., Insulet Corporation, Novo Nordisk A/S, Ypsomed AG, F. Hoffmann-La Roche Ltd., EOFLOW CO., LTD., Terumo Corporation, Sanofi these market players provide a level-playing competitive landscape.

In September 2023, Sanofi collaborated with 35 pharmacies in Berlin to expand its business footprint in Europe.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 15.5% from 2024 to 2032

Unit Value (USD Billion)

Segmentation By Product

- Insulin Pumps

- Insulin Pens

- Insulin Syringes

- Others

By Disease Indication

- Type 1

- Type 2

By Distribution Channel

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

By Region

- North America (By Product, By Disease Indication, By Distribution Channel, and By Country)

- U.S. (By Disease Indication)

- Canada (By Disease Indication)

- Europe (By Product, By Disease Indication, By Distribution Channel, and By Country /Sub-region)

- U.K. (By Disease Indication)

- Germany (By Disease Indication)

- France (By Disease Indication)

- Italy (By Disease Indication)

- Spain (By Disease Indication)

- Scandinavia (By Disease Indication)

- Rest of Europe (By Disease Indication)

- Asia Pacific (By Product, By Disease Indication, By Distribution Channel, and By Country /Sub-region)

- China (By Disease Indication)

- Japan (By Disease Indication)

- India (By Disease Indication)

- Australia (By Disease Indication)

- Southeast Asia (By Disease Indication)

- Rest of Asia Pacific (By Disease Indication)

- Latin America (By Product, By Disease Indication, By Distribution Channel, and By Country /Sub-region)

- Brazil (By Disease Indication)

- Mexico (By Disease Indication)

- Rest of Latin America (By Disease Indication)

- Middle East & Africa (By Product, By Disease Indication, By Distribution Channel, and By Country /Sub-region)

- GCC (By Disease Indication)

- South Africa (By Disease Indication)

- Rest of the Middle East & Africa (By Disease Indication)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

160 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Prevalence of Diabetes (Type 1 and Type 2), Key Countries, 2023
4.2. Overview of Economic Cost Burden of Diabetes, Key Countries/Regions, 2023
4.3. Technological Advancements in Insulin Delivery Devices
4.4. Key Industry Developments – Mergers, Acquisitions & Partnerships
4.5. New Product Launches
4.6. Impact of COVID-19 on the Insulin Delivery Devices Market
5. Global Insulin Delivery Devices Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Product
5.1.1. Insulin Pumps
5.1.2. Insulin Pens
5.1.3. Insulin Syringes
5.1.4. Others
5.2. Market Analysis, Insights and Forecast – By Disease Indication
5.2.1. Type 1
5.2.2. Type 2
5.3. Market Analysis, Insights and Forecast – By Distribution Channel
5.3.1. Hospital Pharmacies
5.3.2. Retail Pharmacies
5.3.3. Online Pharmacies
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Insulin Delivery Devices Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Product
6.1.1. Insulin Pumps
6.1.2. Insulin Pens
6.1.3. Insulin Syringes
6.1.4. Others
6.2. Market Analysis, Insights and Forecast – By Disease Indication
6.2.1. Type 1
6.2.2. Type 2
6.3. Market Analysis, Insights and Forecast – By Distribution Channel
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.1.1. By Disease Indication
6.4.2. Canada
6.4.2.1. By Disease Indication
7. Europe Insulin Delivery Devices Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Product
7.1.1. Insulin Pumps
7.1.2. Insulin Pens
7.1.3. Insulin Syringes
7.1.4. Others
7.2. Market Analysis, Insights and Forecast – By Disease Indication
7.2.1. Type 1
7.2.2. Type 2
7.3. Market Analysis, Insights and Forecast – By Distribution Channel
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.4. Market Analysis, Insights and Forecast – By County/ Sub-region
7.4.1. U.K.
7.4.1.1. By Disease Indication
7.4.2. Germany
7.4.2.1. By Disease Indication
7.4.3. France
7.4.3.1. By Disease Indication
7.4.4. Italy
7.4.4.1. By Disease Indication
7.4.5. Spain
7.4.5.1. By Disease Indication
7.4.6. Scandinavia
7.4.6.1. By Disease Indication
7.4.7. Rest of Europe
7.4.7.1. By Disease Indication
8. Asia Pacific Insulin Delivery Devices Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Product
8.1.1. Insulin Pumps
8.1.2. Insulin Pens
8.1.3. Insulin Syringes
8.1.4. Others
8.2. Market Analysis, Insights and Forecast – By Disease Indication
8.2.1. Type 1
8.2.2. Type 2
8.3. Market Analysis, Insights and Forecast – By Distribution Channel
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.4.1. China
8.4.1.1. By Disease Indication
8.4.2. Japan
8.4.2.1. By Disease Indication
8.4.3. India
8.4.3.1. By Disease Indication
8.4.4. Australia
8.4.4.1. By Disease Indication
8.4.5. Southeast Asia
8.4.5.1. By Disease Indication
8.4.6. Rest of Asia Pacific
8.4.6.1. By Disease Indication
9. Latin America Insulin Delivery Devices Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Product
9.1.1. Insulin Pumps
9.1.2. Insulin Pens
9.1.3. Insulin Syringes
9.1.4. Others
9.2. Market Analysis, Insights and Forecast – By Disease Indication
9.2.1. Type 1
9.2.2. Type 2
9.3. Market Analysis, Insights and Forecast – By Distribution Channel
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
9.4.1. Brazil
9.4.1.1. By Disease Indication
9.4.2. Mexico
9.4.2.1. By Disease Indication
9.4.3. Rest of Latin America
9.4.3.1. By Disease Indication
10. Middle East & Africa Insulin Delivery Devices Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Product
10.1.1. Insulin Pumps
10.1.2. Insulin Pens
10.1.3. Insulin Syringes
10.1.4. Others
10.2. Market Analysis, Insights and Forecast – By Disease Indication
10.2.1. Type 1
10.2.2. Type 2
10.3. Market Analysis, Insights and Forecast – By Distribution Channel
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
10.4.1. GCC
10.4.1.1. By Disease Indication
10.4.2. South Africa
10.4.2.1. By Disease Indication
10.4.3. Rest of Middle East & Africa
10.4.3.1. By Disease Indication
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. Medtronic
11.2.1.1. Overview
11.2.1.2. Products & Services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Tandem Diabetes Care, Inc.
11.2.2.1. Overview
11.2.2.2. Products & Services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Insulet Corporation
11.2.3.1. Overview
11.2.3.2. Products & Services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. Novo Nordisk A/S
11.2.4.1. Overview
11.2.4.2. Products & Services
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Ypsomed AG
11.2.5.1. Overview
11.2.5.2. Products & Services
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. F. Hoffmann-La Roche Ltd.
11.2.6.1. Overview
11.2.6.2. Products & Services
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. EOFLOW CO., LTD
11.2.7.1. Overview
11.2.7.2. Products & Services
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. Terumo Corporation
11.2.8.1. Overview
11.2.8.2. Products & Services
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
11.2.9. Sanofi
11.2.9.1. Overview
11.2.9.2. Products & Services
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. Financials (Based on Availability)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us